Kyonggi-do, South Korea

PilSu Ho


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Location History:

  • Kyonggi-do, KR (2003)
  • Kyunggi-do, KR (2003)

Company Filing History:


Years Active: 2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of PilSu Ho

Introduction: PilSu Ho is a renowned inventor based in Kyonggi-do, South Korea. With a total of two patents to his name, he has made significant strides in the field of medicinal chemistry. His work focuses primarily on developing novel compounds with potential therapeutic applications.

Latest Patents: PilSu Ho's latest inventions include optically active chroman and thiochroman derivatives, specifically the 3-methyl-chromane or thiochromane derivatives. The current invention relates to these compounds, which encompass pharmaceutically acceptable salts, stereoisomers, or hydrates. Moreover, it introduces an anti-estrogenic pharmaceutical composition that utilizes these derivatives as active components, showcasing Ho's commitment to advancing medical science.

Career Highlights: Ho is affiliated with Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company. His innovative work contributes to the organization’s reputation for excellence in drug development and research.

Collaborations: Throughout his career, PilSu Ho has collaborated with distinguished peers such as Kazumi Morikawa and Yoshitake Kanbe, enhancing the impact and breadth of his research. Together, they strive to harness the potential of their inventions for better healthcare solutions.

Conclusion: PilSu Ho's contributions to the pharmaceutical field through his innovative patents demonstrate his dedication and expertise as an inventor. As he continues to explore new avenues in medicinal chemistry, his work is likely to generate significant advancements in the treatment of various conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…